VC  Quaker BioVentures

http://www.quakerbio.com





     Office Locations:

Cira Centre
2929 Arch Street
Philadelphia, PA 19104
Phone: 215-988-6800
Fax: 215-988-6801

 

Stages:

  • Early
  • Expansion
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in 2002, Quaker BioVentures is a venture capital firm dedicated to investing in life science companies located in the Mid-Atlantic region. The firm leads investments in companies across the spectrum of the life science industry, particularly in developing human therapeutic products as well as companies pursuing platform technologies for the biopharmaceutical industry. Quaker also invests in medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at varying stages of development, from early stage businesses to public companies. Quaker manages approximately $700 million in capital, typically investing between $5 million and $25 million in each company, with initial investments ranging from $2.5 million to $12 million. The firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Adele Oliva Partner
    Andrew F. Khouri Vice President
    Brenda D. Gavin Partner
    P. Sherrill Neff Partner
    Richard S. Kollender Partner

     

    Portfolio companies include:


      Achillion
        web link


      Amicus Therapeutics
        web link


      BioLeap
        web link


      Biolex
        web link


      BioRexis
        web link


      Celator Pharmaceuticals
        web link


      Cellatope
        web link


      Cempra
        web link


      CorridorPharma
        web link


      Diasome Pharmaceuticals
        web link


      Discovery Laboratories
        web link


      Durata Therapeutics
        web link


      EKR Therapeutics
        web link


      Eximias
        web link


      Horizon Pharmaceuticals
        web link


      Insmed
        web link


      Intact Vascular
        web link


      MedMark
        web link


      NB Therapeutics
        web link


      Neotropix
        web link


      Neuronetics
        web link


      New York Digital Health Accelerator
        web link


      NovaSom
        web link


      NuPathe
        web link


      Optherion
        web link


      PreCision Dermatology
        web link


      Precision Therapeutics
        web link


      Protez Pharmaeuticals
        web link


      RainDance Technologies
        web link


      Rapid Micro Biosystems
        web link


      Regado
        web link


      Semprae
        web link


      TargetRx
        web link


      Tarsa Therapeutics
        web link


      TearScience
        web link


      Tengion
        web link


      TetraLogic
        web link


      TransEnterix
        web link


      Tranzyme Pharmaceuticals
        web link


     

    Recent News: